Immunomodulators provide no reduction in loss of response for inflammatory bowel disease patients starting anti-TNF-alpha therapy

被引：0
|
作者：
Varma, P. [1 ]
Yeaman, F. [1 ]
Holt, D. [1 ]
Moore, G. [1 ]
机构：
[1] Monash Hlth, Dept Gastroenterol, Clayton, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [1] Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease
    Lucendo, Alfredo J.
    Roncero, Oscar
    Teresa Serrano-Duenas, Maria
    Hervías, Daniel
    Miguel Alcazar, Luis
    Miriam-Ruiz-Ponce
    Verdejo, Cristina
    Laserna-Mendieta, Emilio
    Lorente, Rufo
    Arias, Angel
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 (04) : 400 - 407
  • [2] Prior Anti-TNF-Alpha Exposure Is Associated with Ustekinumab Dose Escalation in Patients With Inflammatory Bowel Disease
    Tran, Nancy
    Lavergne, Alexa
    Scherl, Ellen
    Longman, Randy
    Lukin, Dana
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S907 - S908
  • [3] Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies
    Beigel, Florian
    Deml, Matthias
    Schnitzler, Fabian
    Breiteneicher, Simone
    Goeke, Burkhard
    Ochsenkuehn, Thomas
    Brand, Stephan
    [J]. PLOS ONE, 2014, 9 (06):
  • [4] Vedolizumab is an effective alternative in inflammatory bowel disease patients with anti-TNF-alpha therapy-induced dermatological side effects
    Pijls, Philippe A. R. R.
    Gilissen, Lennard P. L.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (11) : 1391 - 1393
  • [5] Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease
    Lucas Ramos, Javier
    Suarez Ferrer, Cristina
    Poza Cordon, Joaquin
    Sanchez Azofra, Maria
    Rueda Garcia, Jose Luis
    Martin Arranz, Eduardo
    Yebra Carmona, Jorge
    Andaluz Garcia, Irene
    Martin Arranz, Maria Dolores
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (05): : 337 - 345
  • [6] Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature
    Parekh, Ravish
    Kaur, Nirmal
    [J]. CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2014, 2014
  • [7] Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis
    Wang, Fan
    Lin, Xue
    Zhao, Qiu
    Li, Jin
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (08) : 911 - 919
  • [8] Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis
    Fan Wang
    Xue Lin
    Qiu Zhao
    Jin Li
    [J]. European Journal of Clinical Pharmacology, 2015, 71 : 911 - 919
  • [9] The addition of an immunosuppressant is an effective optimization strategy after loss of response to anti-TNF-alpha monotherapy in patients with inflammatory bowel disease: a two-year experience
    Macaluso, F. S.
    Sapienza, C.
    Ventimiglia, M.
    Renna, S.
    Rizzuto, G.
    Orlando, R.
    Affronti, M.
    Orlando, E.
    Cottone, M.
    Orlando, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S274 - S274
  • [10] Anti-TNF alpha therapy in Inflammatory Bowel Disease - safety profile in elderly patients
    Bernardes, C.
    Carvalho, D.
    Russo, P.
    Saiote, J.
    Ramos, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S400 - S400
12345